Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin

This document is a response-to-comments notice for the LCD concerning allogeneic hematopoietic cell transplantation for primary refractory or relapsed Hodgkin and Non-Hodgkin lymphoma of B-cell or T-cell origin. It announces that public/provider comments were solicited, the official notice period begins June 15, 2023, and the final LCD becomes effective August 1, 2023.

"National Government Services solicits written comments from the provider community and public as part of LCD development for Allogeneic Hematopoietic Cell Transplantation for primary refractory or ..."

Sign up to see full coverage criteria, indications, and limitations.